在世界范围内大约20个实验中约1000例患者接受治疗，大多数使用骨髓干细胞或骨髓细胞衍生物来修复心脏病导致的损害。
Around 1000 patients have been treated in approximately 20 trials worldwide, mostly using bone marrow stem cells or derivatives of bone marrow cells to repair damage caused by heart attack.
目的探讨骨髓间充质干细胞复合骨生物衍生材料异位成骨的可行性和成骨能力。
Objective to investigate the ectopic osteogenesis potential of human natural bone derived material combined with human Mesenchymal Stem Cells.
研究发现，SO_2及其衍生物可引起人外周血淋巴细胞、小鼠骨髓细胞、中国仓鼠肺成纤维细胞等哺乳动物细胞的染色体畸变、姊妹染色单体交换及微核的形成。
Several studies have shown that SO2 and its derivatives could induce chromosomal aberrations, sister chromatid exchanges and micronuclei in human blood lymphocyte, bone marrow cell in mice and CHL.
应用推荐